Αποτελέσματα Αναζήτησης
11 Σεπ 2024 · Cancer treatment side effects associated with fatigue include anemia, pain, insomnia, poor nutrition, sedentariness, anxiety and depression. Hormone therapies for certain cancers and hormone-sensitive cancers can disrupt hormone levels, which also can lead to fatigue.
20 Σεπ 2024 · Cancer fatigue can occur at any time. Fatigue can begin at any time—before, during, or after cancer treatment. Sometimes it’s an early symptom of cancer, or it can be brought on by the stress of a cancer diagnosis. Fatigue may worsen gradually as you go through treatment, or it may come on suddenly.
Fatigue affects most people during cancer treatment. Cancer fatigue can result from the side effects of treatment or the cancer itself. Here's a look at the causes and what you can do to cope when you're feeling fatigued.
15 Οκτ 2024 · Cancer cachexia is a wasting syndrome that leads to weakness, fatigue, and loss of skeletal muscle (also called sarcopenia) and fat. Unlike malnutrition, it cannot be reversed with nutrition support alone. Cancer cachexia must be treated with medicines and is hard to reverse once it starts. Cancer cachexia is most common in people with advanced ...
17 Ιουλ 2024 · Cancer-related fatigue (CRF) is a distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer treatment that is not proportional to recent activity and interferes with usual functioning. [1] .
Cancer-related fatigue (CRF) is a severe form of fatigue among people with cancer. It is described as an overwhelming tiredness, exhaustion and weakness that doesn’t go away with sleep and rest. Even though CRF has a lot of the same symptoms as depression, the condition is considered its own primary symptom of cancer and cancer treatment.
30 Ιουλ 2024 · Fatigue is routinely identified by patients as one of the most distressing symptoms associated with cancer and its treatment, yet historically it has been consistently underreported and overlooked as a potentially remediable cause of treatment-related morbidity [8].
